A pair of spacecraft developed by private firms blast off on a single rocket on the risky voyage to the lunar surface.

The range of scientific opinion favoring increased vitamin ... an endocrinologist at Boston University Medical Center. Holick summarizes his views and research in a recent review (Holick, 2011 ...

Shares of Boston Scientific Corp. BSX advanced 1.30% to $96.89 Wednesday, on what proved to be an all-around great trading ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $95.65 which represents a slight increase of $1.04 or 1.10% from the prior close of $94.61. The stock opened at $95.08 and ...

This was the stock's second consecutive day of losses.

Deutsche Bank upgraded Boston Scientific (BSX) to Buy from Hold with a price target of $108, up from $87. Boston Scientific’s :story has become ...

On the financial side, the company reported strong third-quarter 2024 results, with net sales of $4.209 billion — a 19.4% ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $94.88 which represents a decrease of $-1.07 or -1.12% from the prior close of $95.95. The stock opened at $95.48 and touched a low ...